Teladoc Health, Inc. - Common Stock (TDOC)

CUSIP: 87918A105

Q2 2020 13F Holders as of 30 Jun 2020

Holder snapshot 7 signals
Share change
-1,344,932
Put/Call ratio
96%
SEC-reported price per share
$190.84
Indexed holders
654
Value change
-$180,652,715
Number of buys
354
Open additional details 1 more signal available
Number of sells
299
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
182,921,596

Security key

87918A105

Report period

Q2 2020

Indexed institutions

654

Top holders

10

Ownership snapshot

Top reported holders of TDOC - Teladoc Health, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
31 Mar 2020
13F Highest disclosed value: $1,177,285,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. has the largest disclosed position value at $1.18B.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value Top 5
BlackRock Finance, Inc. $1.18B
VANGUARD GROUP INC $1.06B
BAILLIE GIFFORD & CO $895.03M
JPMORGAN CHASE & CO $489.02M
BANK OF AMERICA CORP /DE/ $365.96M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$1,177,285,000
7,594,901 shares
— 31 Mar 2020
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$1,058,106,000
6,826,048 shares
— 31 Mar 2020
BAILLIE GIFFORD & CO
13F
Company
13F
—
denominator unverified
$895,028,000
5,774,002 shares
— 31 Mar 2020
JPMORGAN CHASE & CO
13F
Company
13F
—
denominator unverified
$489,017,000
3,154,743 shares
— 31 Mar 2020
BANK OF AMERICA CORP /DE/
13F
Company
13F
—
denominator unverified
$365,958,000
2,360,874 shares
— 31 Mar 2020
WADDELL & REED FINANCIAL INC
13F
Company
13F
—
denominator unverified
$262,007,000
1,690,256 shares
— 31 Mar 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
654
Shares
71,460,376
Indexed holders
654
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 indexed holders
559
Q2 2020 indexed holders
654
Indexed holder difference
95
Investor Q1 2020 Shares Q2 2020 Shares Share Diff Share Chg % Q1 2020 value Q2 2020 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .